Report Cover

Global Ropivacaine Market Research Report 2021


The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
    Lumbar Epidural Administration
    Thoracic Epidural Administration
    Regional Block

Segment by Application
    Anesthesia
    Systemic Neuropathic Pain
    Postherpes Pain
    Post-Operative Pain
    Surgical Analgesia
    Labor Analgesia
    Other

By Region
    North America
        U.S.
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        Taiwan
        Indonesia
        Thailand
        Malaysia
        Philippines
        Vietnam
    Latin America
        Mexico
        Brazil
        Argentina
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE

By Company
    AstraZeneca
    Aspen Pharmacare
    Celgene
    Taiwan Liposome Company
    Nuvo Pharmaceuticals
    Heron Therapeutics
    Encore Therapeutics
    PainReform Ltd
    Anhui Wellman Pharmaceutical
    Yichang Renfu Pharmaceutical
    Shandong New Era Pharmaceutical
    Shanxi Pude Pharmaceutical
    Guangdong Huarun Shunfeng Pharmaceutical
    Guangdong Jiabo Pharmaceutical
    Chengdu Tiantaishan Pharmaceutical
    Yangtze Pharmaceutical Group
    Jiangsu Hengrui Pharmaceutical
    Jiangsu Enhua Pharmaceutical
    Hebei Yipin Pharmaceutical
    Zhejiang Xianju Pharmaceutical
    Hainan Sida Pharmaceutical
    Xi'an Hanfeng Pharmaceutical
    Chenxin Pharmaceutical
    Shaanxi Bosen Biopharmaceutical
    Qilu Pharmaceutical
    Shenyang Sansheng Pharmaceutical
1 Ropivacaine Market Overview
    1.1 Product Overview and Scope of Ropivacaine
    1.2 Ropivacaine Segment by Type
        1.2.1 Global Ropivacaine Sales Growth Rate Comparison by Type (2021-2027)
        1.2.2 Lumbar Epidural Administration
        1.2.3 Thoracic Epidural Administration
        1.2.4 Regional Block
    1.3 Ropivacaine Segment by Application
        1.3.1 Ropivacaine Sales Comparison by Application: (2021-2027)
        1.3.2 Anesthesia
        1.3.3 Systemic Neuropathic Pain
        1.3.4 Postherpes Pain
        1.3.5 Post-Operative Pain
        1.3.6 Surgical Analgesia
        1.3.7 Labor Analgesia
        1.3.8 Other
    1.4 Global Ropivacaine Market Size Estimates and Forecasts
        1.4.1 Global Ropivacaine Revenue 2016-2027
        1.4.2 Global Ropivacaine Sales 2016-2027
        1.4.3 Ropivacaine Market Size by Region: 2016 Versus 2021 Versus 2027

2 Ropivacaine Market Competition by Manufacturers
    2.1 Global Ropivacaine Sales Market Share by Manufacturers (2016-2021)
    2.2 Global Ropivacaine Revenue Market Share by Manufacturers (2016-2021)
    2.3 Global Ropivacaine Average Price by Manufacturers (2016-2021)
    2.4 Manufacturers Ropivacaine Manufacturing Sites, Area Served, Product Type
    2.5 Ropivacaine Market Competitive Situation and Trends
        2.5.1 Ropivacaine Market Concentration Rate
        2.5.2 The Global Top 5 and Top 10 Largest Ropivacaine Players Market Share by Revenue
        2.5.3 Global Ropivacaine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Ropivacaine Retrospective Market Scenario by Region
    3.1 Global Ropivacaine Retrospective Market Scenario in Revenue by Region: 2016-2021
    3.2 Global Ropivacaine Retrospective Market Scenario in Sales by Region: 2016-2021
    3.3 North America Ropivacaine Market Facts & Figures by Country
        3.3.1 North America Ropivacaine Sales by Country
        3.3.2 North America Ropivacaine Revenue by Country
        3.3.3 U.S.
        3.3.4 Canada
    3.4 Europe Ropivacaine Market Facts & Figures by Country
        3.4.1 Europe Ropivacaine Sales by Country
        3.4.2 Europe Ropivacaine Revenue by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific Ropivacaine Market Facts & Figures by Region
        3.5.1 Asia Pacific Ropivacaine Sales by Region
        3.5.2 Asia Pacific Ropivacaine Revenue by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
        3.5.12 Philippines
        3.5.13 Vietnam
    3.6 Latin America Ropivacaine Market Facts & Figures by Country
        3.6.1 Latin America Ropivacaine Sales by Country
        3.6.2 Latin America Ropivacaine Revenue by Country
        3.6.3 Mexico
        3.6.4 Brazil
        3.6.5 Argentina
    3.7 Middle East and Africa Ropivacaine Market Facts & Figures by Country
        3.7.1 Middle East and Africa Ropivacaine Sales by Country
        3.7.2 Middle East and Africa Ropivacaine Revenue by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 UAE
4 Global Ropivacaine Historic Market Analysis by Type
    4.1 Global Ropivacaine Sales Market Share by Type (2016-2021)
    4.2 Global Ropivacaine Revenue Market Share by Type (2016-2021)
    4.3 Global Ropivacaine Price by Type (2016-2021)

5 Global Ropivacaine Historic Market Analysis by Application
    5.1 Global Ropivacaine Sales Market Share by Application (2016-2021)
    5.2 Global Ropivacaine Revenue Market Share by Application (2016-2021)
    5.3 Global Ropivacaine Price by Application (2016-2021)

6 Key Companies Profiled
    6.1 AstraZeneca
        6.1.1 AstraZeneca Corporation Information
        6.1.2 AstraZeneca Description and Business Overview
        6.1.3 AstraZeneca Ropivacaine Sales, Revenue and Gross Margin (2016-2021)
        6.1.4 AstraZeneca Product Portfolio
        6.1.5 AstraZeneca Recent Developments/Updates
    6.2 Aspen Pharmacare
        6.2.1 Aspen Pharmacare Corporation Information
        6.2.2 Aspen Pharmacare Description and Business Overview
        6.2.3 Aspen Pharmacare Ropivacaine Sales, Revenue and Gross Margin (2016-2021)
        6.2.4 Aspen Pharmacare Product Portfolio
        6.2.5 Aspen Pharmacare Recent Developments/Updates
    6.3 Celgene
        6.3.1 Celgene Corporation Information
        6.3.2 Celgene Description and Business Overview
        6.3.3 Celgene Ropivacaine Sales, Revenue and Gross Margin (2016-2021)
        6.3.4 Celgene Product Portfolio
        6.3.5 Celgene Recent Developments/Updates
    6.4 Taiwan Liposome Company
        6.4.1 Taiwan Liposome Company Corporation Information
        6.4.2 Taiwan Liposome Company Description and Business Overview
        6.4.3 Taiwan Liposome Company Ropivacaine Sales, Revenue and Gross Margin (2016-2021)
        6.4.4 Taiwan Liposome Company Product Portfolio
        6.4.5 Taiwan Liposome Company Recent Developments/Updates
    6.5 Nuvo Pharmaceuticals
        6.5.1 Nuvo Pharmaceuticals Corporation Information
        6.5.2 Nuvo Pharmaceuticals Description and Business Overview
        6.5.3 Nuvo Pharmaceuticals Ropivacaine Sales, Revenue and Gross Margin (2016-2021)
        6.5.4 Nuvo Pharmaceuticals Product Portfolio
        6.5.5 Nuvo Pharmaceuticals Recent Developments/Updates
    6.6 Heron Therapeutics
        6.6.1 Heron Therapeutics Corporation Information
        6.6.2 Heron Therapeutics Description and Business Overview
        6.6.3 Heron Therapeutics Ropivacaine Sales, Revenue and Gross Margin (2016-2021)
        6.6.4 Heron Therapeutics Product Portfolio
        6.6.5 Heron Therapeutics Recent Developments/Updates
    6.7 Encore Therapeutics
        6.6.1 Encore Therapeutics Corporation Information
        6.6.2 Encore Therapeutics Description and Business Overview
        6.6.3 Encore Therapeutics Ropivacaine Sales, Revenue and Gross Margin (2016-2021)
        6.4.4 Encore Therapeutics Product Portfolio
        6.7.5 Encore Therapeutics Recent Developments/Updates
    6.8 PainReform Ltd
        6.8.1 PainReform Ltd Corporation Information
        6.8.2 PainReform Ltd Description and Business Overview
        6.8.3 PainReform Ltd Ropivacaine Sales, Revenue and Gross Margin (2016-2021)
        6.8.4 PainReform Ltd Product Portfolio
        6.8.5 PainReform Ltd Recent Developments/Updates
    6.9 Anhui Wellman Pharmaceutical
        6.9.1 Anhui Wellman Pharmaceutical Corporation Information
        6.9.2 Anhui Wellman Pharmaceutical Description and Business Overview
        6.9.3 Anhui Wellman Pharmaceutical Ropivacaine Sales, Revenue and Gross Margin (2016-2021)
        6.9.4 Anhui Wellman Pharmaceutical Product Portfolio
        6.9.5 Anhui Wellman Pharmaceutical Recent Developments/Updates
    6.10 Yichang Renfu Pharmaceutical
        6.10.1 Yichang Renfu Pharmaceutical Corporation Information
        6.10.2 Yichang Renfu Pharmaceutical Description and Business Overview
        6.10.3 Yichang Renfu Pharmaceutical Ropivacaine Sales, Revenue and Gross Margin (2016-2021)
        6.10.4 Yichang Renfu Pharmaceutical Product Portfolio
        6.10.5 Yichang Renfu Pharmaceutical Recent Developments/Updates
    6.11 Shandong New Era Pharmaceutical
        6.11.1 Shandong New Era Pharmaceutical Corporation Information
        6.11.2 Shandong New Era Pharmaceutical Ropivacaine Description and Business Overview
        6.11.3 Shandong New Era Pharmaceutical Ropivacaine Sales, Revenue and Gross Margin (2016-2021)
        6.11.4 Shandong New Era Pharmaceutical Product Portfolio
        6.11.5 Shandong New Era Pharmaceutical Recent Developments/Updates
    6.12 Shanxi Pude Pharmaceutical
        6.12.1 Shanxi Pude Pharmaceutical Corporation Information
        6.12.2 Shanxi Pude Pharmaceutical Ropivacaine Description and Business Overview
        6.12.3 Shanxi Pude Pharmaceutical Ropivacaine Sales, Revenue and Gross Margin (2016-2021)
        6.12.4 Shanxi Pude Pharmaceutical Product Portfolio
        6.12.5 Shanxi Pude Pharmaceutical Recent Developments/Updates
    6.13 Guangdong Huarun Shunfeng Pharmaceutical
        6.13.1 Guangdong Huarun Shunfeng Pharmaceutical Corporation Information
        6.13.2 Guangdong Huarun Shunfeng Pharmaceutical Ropivacaine Description and Business Overview
        6.13.3 Guangdong Huarun Shunfeng Pharmaceutical Ropivacaine Sales, Revenue and Gross Margin (2016-2021)
        6.13.4 Guangdong Huarun Shunfeng Pharmaceutical Product Portfolio
        6.13.5 Guangdong Huarun Shunfeng Pharmaceutical Recent Developments/Updates
    6.14 Guangdong Jiabo Pharmaceutical
        6.14.1 Guangdong Jiabo Pharmaceutical Corporation Information
        6.14.2 Guangdong Jiabo Pharmaceutical Ropivacaine Description and Business Overview
        6.14.3 Guangdong Jiabo Pharmaceutical Ropivacaine Sales, Revenue and Gross Margin (2016-2021)
        6.14.4 Guangdong Jiabo Pharmaceutical Product Portfolio
        6.14.5 Guangdong Jiabo Pharmaceutical Recent Developments/Updates
    6.15 Chengdu Tiantaishan Pharmaceutical
        6.15.1 Chengdu Tiantaishan Pharmaceutical Corporation Information
        6.15.2 Chengdu Tiantaishan Pharmaceutical Ropivacaine Description and Business Overview
        6.15.3 Chengdu Tiantaishan Pharmaceutical Ropivacaine Sales, Revenue and Gross Margin (2016-2021)
        6.15.4 Chengdu Tiantaishan Pharmaceutical Product Portfolio
        6.15.5 Chengdu Tiantaishan Pharmaceutical Recent Developments/Updates
    6.16 Yangtze Pharmaceutical Group
        6.16.1 Yangtze Pharmaceutical Group Corporation Information
        6.16.2 Yangtze Pharmaceutical Group Ropivacaine Description and Business Overview
        6.16.3 Yangtze Pharmaceutical Group Ropivacaine Sales, Revenue and Gross Margin (2016-2021)
        6.16.4 Yangtze Pharmaceutical Group Product Portfolio
        6.16.5 Yangtze Pharmaceutical Group Recent Developments/Updates
    6.17 Jiangsu Hengrui Pharmaceutical
        6.17.1 Jiangsu Hengrui Pharmaceutical Corporation Information
        6.17.2 Jiangsu Hengrui Pharmaceutical Ropivacaine Description and Business Overview
        6.17.3 Jiangsu Hengrui Pharmaceutical Ropivacaine Sales, Revenue and Gross Margin (2016-2021)
        6.17.4 Jiangsu Hengrui Pharmaceutical Product Portfolio
        6.17.5 Jiangsu Hengrui Pharmaceutical Recent Developments/Updates
    6.18 Jiangsu Enhua Pharmaceutical
        6.18.1 Jiangsu Enhua Pharmaceutical Corporation Information
        6.18.2 Jiangsu Enhua Pharmaceutical Ropivacaine Description and Business Overview
        6.18.3 Jiangsu Enhua Pharmaceutical Ropivacaine Sales, Revenue and Gross Margin (2016-2021)
        6.18.4 Jiangsu Enhua Pharmaceutical Product Portfolio
        6.18.5 Jiangsu Enhua Pharmaceutical Recent Developments/Updates
    6.19 Hebei Yipin Pharmaceutical
        6.19.1 Hebei Yipin Pharmaceutical Corporation Information
        6.19.2 Hebei Yipin Pharmaceutical Ropivacaine Description and Business Overview
        6.19.3 Hebei Yipin Pharmaceutical Ropivacaine Sales, Revenue and Gross Margin (2016-2021)
        6.19.4 Hebei Yipin Pharmaceutical Product Portfolio
        6.19.5 Hebei Yipin Pharmaceutical Recent Developments/Updates
    6.20 Zhejiang Xianju Pharmaceutical
        6.20.1 Zhejiang Xianju Pharmaceutical Corporation Information
        6.20.2 Zhejiang Xianju Pharmaceutical Ropivacaine Description and Business Overview
        6.20.3 Zhejiang Xianju Pharmaceutical Ropivacaine Sales, Revenue and Gross Margin (2016-2021)
        6.20.4 Zhejiang Xianju Pharmaceutical Product Portfolio
        6.20.5 Zhejiang Xianju Pharmaceutical Recent Developments/Updates
    6.21 Hainan Sida Pharmaceutical
        6.21.1 Hainan Sida Pharmaceutical Corporation Information
        6.21.2 Hainan Sida Pharmaceutical Ropivacaine Description and Business Overview
        6.21.3 Hainan Sida Pharmaceutical Ropivacaine Sales, Revenue and Gross Margin (2016-2021)
        6.21.4 Hainan Sida Pharmaceutical Product Portfolio
        6.21.5 Hainan Sida Pharmaceutical Recent Developments/Updates
    6.22 Xi'an Hanfeng Pharmaceutical
        6.22.1 Xi'an Hanfeng Pharmaceutical Corporation Information
        6.22.2 Xi'an Hanfeng Pharmaceutical Ropivacaine Description and Business Overview
        6.22.3 Xi'an Hanfeng Pharmaceutical Ropivacaine Sales, Revenue and Gross Margin (2016-2021)
        6.22.4 Xi'an Hanfeng Pharmaceutical Product Portfolio
        6.22.5 Xi'an Hanfeng Pharmaceutical Recent Developments/Updates
    6.23 Chenxin Pharmaceutical
        6.23.1 Chenxin Pharmaceutical Corporation Information
        6.23.2 Chenxin Pharmaceutical Ropivacaine Description and Business Overview
        6.23.3 Chenxin Pharmaceutical Ropivacaine Sales, Revenue and Gross Margin (2016-2021)
        6.23.4 Chenxin Pharmaceutical Product Portfolio
        6.23.5 Chenxin Pharmaceutical Recent Developments/Updates
    6.24 Shaanxi Bosen Biopharmaceutical
        6.24.1 Shaanxi Bosen Biopharmaceutical Corporation Information
        6.24.2 Shaanxi Bosen Biopharmaceutical Ropivacaine Description and Business Overview
        6.24.3 Shaanxi Bosen Biopharmaceutical Ropivacaine Sales, Revenue and Gross Margin (2016-2021)
        6.24.4 Shaanxi Bosen Biopharmaceutical Product Portfolio
        6.24.5 Shaanxi Bosen Biopharmaceutical Recent Developments/Updates
    6.25 Qilu Pharmaceutical
        6.25.1 Qilu Pharmaceutical Corporation Information
        6.25.2 Qilu Pharmaceutical Ropivacaine Description and Business Overview
        6.25.3 Qilu Pharmaceutical Ropivacaine Sales, Revenue and Gross Margin (2016-2021)
        6.25.4 Qilu Pharmaceutical Product Portfolio
        6.25.5 Qilu Pharmaceutical Recent Developments/Updates
    6.26 Shenyang Sansheng Pharmaceutical
        6.26.1 Shenyang Sansheng Pharmaceutical Corporation Information
        6.26.2 Shenyang Sansheng Pharmaceutical Ropivacaine Description and Business Overview
        6.26.3 Shenyang Sansheng Pharmaceutical Ropivacaine Sales, Revenue and Gross Margin (2016-2021)
        6.26.4 Shenyang Sansheng Pharmaceutical Product Portfolio
        6.26.5 Shenyang Sansheng Pharmaceutical Recent Developments/Updates

7 Ropivacaine Manufacturing Cost Analysis
    7.1 Ropivacaine Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of Ropivacaine
    7.4 Ropivacaine Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 Ropivacaine Distributors List
    8.3 Ropivacaine Customers

9 Ropivacaine Market Dynamics
    9.1 Ropivacaine Industry Trends
    9.2 Ropivacaine Growth Drivers
    9.3 Ropivacaine Market Challenges
    9.4 Ropivacaine Market Restraints

10 Global Market Forecast
    10.1 Ropivacaine Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of Ropivacaine by Type (2022-2027)
        10.1.2 Global Forecasted Revenue of Ropivacaine by Type (2022-2027)
    10.2 Ropivacaine Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of Ropivacaine by Application (2022-2027)
        10.2.2 Global Forecasted Revenue of Ropivacaine by Application (2022-2027)
    10.3 Ropivacaine Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of Ropivacaine by Region (2022-2027)
        10.3.2 Global Forecasted Revenue of Ropivacaine by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer

List of Tables Table 1. Global Ropivacaine Sales (K Doses) Growth Rate Comparison by Type (2021-2027) Table 2. Global Ropivacaine Sales (K Doses) Comparison by Application (2021-2027) Table 3. Global Ropivacaine Market Size by Region (US$ Million) (2016 VS 2021 VS 2027) Table 4. Key Manufacturers Ropivacaine Covered in This Study Table 5. Global Ropivacaine Sales (K Doses) of Key Manufacturers (2016-2021) Table 6. Global Ropivacaine Sales Share by Manufacturers (2016-2021) Table 7. Global Ropivacaine Revenue (US$ Million) by Manufacturers (2016-2021) Table 8. Global Ropivacaine Revenue Share by Manufacturers (2016-2021) Table 9. Global Market Ropivacaine Average Price (US$/Dose) of Key Manufacturers (2016-2021) Table 10. Manufacturers Ropivacaine Manufacturing Sites and Area Served Table 11. Manufacturers Ropivacaine Product Type Table 12. Global Ropivacaine Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Ropivacaine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ropivacaine as of 2020) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Ropivacaine Sales by Region (2016-2021) & (K Doses) Table 16. Global Ropivacaine Sales Market Share by Region (2016-2021) Table 17. Global Ropivacaine Revenue by Region (2016-2021) & (US$ Million) Table 18. North America Ropivacaine Sales by Country (2016-2021) & (K Doses) Table 19. North America Ropivacaine Sales Market Share by Country (2016-2021) Table 20. North America Ropivacaine Revenue by Country (2016-2021) & (US$ Million) Table 21. North America Ropivacaine Revenue Market Share by Country (2016-2021) Table 22. Europe Ropivacaine Sales by Country (2016-2021) & (K Doses) Table 23. Europe Ropivacaine Sales Market Share by Country (2016-2021) Table 24. Europe Ropivacaine Revenue by Country (2016-2021) & (US$ Million) Table 25. Europe Ropivacaine Revenue Market Share by Country (2016-2021) Table 26. Asia Pacific Ropivacaine Sales by Region (2016-2021) & (K Doses) Table 27. Asia Pacific Ropivacaine Sales Market Share by Region (2016-2021) Table 28. Asia Pacific Ropivacaine Revenue by Region (2016-2021) & (US$ Million) Table 29. Asia Pacific Ropivacaine Revenue Market Share by Region (2016-2021) Table 30. Latin America Ropivacaine Sales by Country (2016-2021) & (K Doses) Table 31. Latin America Ropivacaine Sales Market Share by Country (2016-2021) Table 32. Latin America Ropivacaine Revenue by Country (2016-2021) & (US$ Million) Table 33. Latin America Ropivacaine Revenue Market Share by Country (2016-2021) Table 34. Middle East and Africa Ropivacaine Sales by Country (2016-2021) & (K Doses) Table 35. Middle East and Africa Ropivacaine Sales Market Share by Country (2016-2021) Table 36. Middle East and Africa Ropivacaine Revenue by Country (2016-2021) & (US$ Million) Table 37. Middle East and Africa Ropivacaine Revenue Market Share by Country (2016-2021) Table 38. Global Ropivacaine Sales (K Doses) by Type (2016-2021) Table 39. Global Ropivacaine Sales Market Share by Type (2016-2021) Table 40. Global Ropivacaine Revenue (Million US$) by Type (2016-2021) Table 41. Global Ropivacaine Revenue Share by Type (2016-2021) Table 42. Global Ropivacaine Price (US$/Dose) by Type (2016-2021) Table 43. Global Ropivacaine Sales (K Doses) by Application (2016-2021) Table 44. Global Ropivacaine Sales Market Share by Application (2016-2021) Table 45. Global Ropivacaine Revenue (Million US$) by Application (2016-2021) Table 46. Global Ropivacaine Revenue Share by Application (2016-2021) Table 47. Global Ropivacaine Price (US$/Dose) by Application (2016-2021) Table 48. AstraZeneca Corporation Information Table 49. AstraZeneca Description and Business Overview Table 50. AstraZeneca Ropivacaine Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2016-2021) Table 51. AstraZeneca Ropivacaine Product Table 52. AstraZeneca Recent Developments/Updates Table 53. Aspen Pharmacare Corporation Information Table 54. Aspen Pharmacare Description and Business Overview Table 55. Aspen Pharmacare Ropivacaine Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2016-2021) Table 56. Aspen Pharmacare Ropivacaine Product Table 57. Aspen Pharmacare Recent Developments/Updates Table 58. Celgene Corporation Information Table 59. Celgene Description and Business Overview Table 60. Celgene Ropivacaine Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2016-2021) Table 61. Celgene Ropivacaine Product Table 62. Celgene Recent Developments/Updates Table 63. Taiwan Liposome Company Corporation Information Table 64. Taiwan Liposome Company Description and Business Overview Table 65. Taiwan Liposome Company Ropivacaine Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2016-2021) Table 66. Taiwan Liposome Company Ropivacaine Product Table 67. Taiwan Liposome Company Recent Developments/Updates Table 68. Nuvo Pharmaceuticals Corporation Information Table 69. Nuvo Pharmaceuticals Description and Business Overview Table 70. Nuvo Pharmaceuticals Ropivacaine Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2016-2021) Table 71. Nuvo Pharmaceuticals Ropivacaine Product Table 72. Nuvo Pharmaceuticals Recent Developments/Updates Table 73. Heron Therapeutics Corporation Information Table 74. Heron Therapeutics Description and Business Overview Table 75. Heron Therapeutics Ropivacaine Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2016-2021) Table 76. Heron Therapeutics Ropivacaine Product Table 77. Heron Therapeutics Recent Developments/Updates Table 78. Encore Therapeutics Corporation Information Table 79. Encore Therapeutics Description and Business Overview Table 80. Encore Therapeutics Ropivacaine Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2016-2021) Table 81. Encore Therapeutics Ropivacaine Product Table 82. Encore Therapeutics Recent Developments/Updates Table 83. PainReform Ltd Corporation Information Table 84. PainReform Ltd Description and Business Overview Table 85. PainReform Ltd Ropivacaine Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2016-2021) Table 86. PainReform Ltd Ropivacaine Product Table 87. PainReform Ltd Recent Developments/Updates Table 88. Anhui Wellman Pharmaceutical Corporation Information Table 89. Anhui Wellman Pharmaceutical Description and Business Overview Table 90. Anhui Wellman Pharmaceutical Ropivacaine Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2016-2021) Table 91. Anhui Wellman Pharmaceutical Ropivacaine Product Table 92. Anhui Wellman Pharmaceutical Recent Developments/Updates Table 93. Yichang Renfu Pharmaceutical Corporation Information Table 94. Yichang Renfu Pharmaceutical Description and Business Overview Table 95. Yichang Renfu Pharmaceutical Ropivacaine Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2016-2021) Table 96. Yichang Renfu Pharmaceutical Ropivacaine Product Table 97. Yichang Renfu Pharmaceutical Recent Developments/Updates Table 98. Shandong New Era Pharmaceutical Corporation Information Table 99. Shandong New Era Pharmaceutical Description and Business Overview Table 100. Shandong New Era Pharmaceutical Ropivacaine Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2016-2021) Table 101. Shandong New Era Pharmaceutical Ropivacaine Product Table 102. Shandong New Era Pharmaceutical Recent Developments/Updates Table 103. Shanxi Pude Pharmaceutical Corporation Information Table 104. Shanxi Pude Pharmaceutical Description and Business Overview Table 105. Shanxi Pude Pharmaceutical Ropivacaine Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2016-2021) Table 106. Shanxi Pude Pharmaceutical Ropivacaine Product Table 107. Shanxi Pude Pharmaceutical Recent Developments/Updates Table 108. Guangdong Huarun Shunfeng Pharmaceutical Corporation Information Table 109. Guangdong Huarun Shunfeng Pharmaceutical Description and Business Overview Table 110. Guangdong Huarun Shunfeng Pharmaceutical Ropivacaine Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2016-2021) Table 111. Guangdong Huarun Shunfeng Pharmaceutical Ropivacaine Product Table 112. Guangdong Huarun Shunfeng Pharmaceutical Recent Developments/Updates Table 113. Guangdong Jiabo Pharmaceutical Corporation Information Table 114. Guangdong Jiabo Pharmaceutical Description and Business Overview Table 115. Guangdong Jiabo Pharmaceutical Ropivacaine Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2016-2021) Table 116. Guangdong Jiabo Pharmaceutical Ropivacaine Product Table 117. Guangdong Jiabo Pharmaceutical Recent Developments/Updates Table 118. Chengdu Tiantaishan Pharmaceutical Corporation Information Table 119. Chengdu Tiantaishan Pharmaceutical Description and Business Overview Table 120. Chengdu Tiantaishan Pharmaceutical Ropivacaine Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2016-2021) Table 121. Chengdu Tiantaishan Pharmaceutical Ropivacaine Product Table 122. Chengdu Tiantaishan Pharmaceutical Recent Developments/Updates Table 123. Yangtze Pharmaceutical Group Corporation Information Table 124. Yangtze Pharmaceutical Group Description and Business Overview Table 125. Yangtze Pharmaceutical Group Ropivacaine Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2016-2021) Table 126. Yangtze Pharmaceutical Group Ropivacaine Product Table 127. Yangtze Pharmaceutical Group Recent Developments/Updates Table 128. Jiangsu Hengrui Pharmaceutical Corporation Information Table 129. Jiangsu Hengrui Pharmaceutical Description and Business Overview Table 130. Jiangsu Hengrui Pharmaceutical Ropivacaine Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2016-2021) Table 131. Jiangsu Hengrui Pharmaceutical Ropivacaine Product Table 132. Jiangsu Hengrui Pharmaceutical Recent Developments/Updates Table 133. Jiangsu Enhua Pharmaceutical Corporation Information Table 134. Jiangsu Enhua Pharmaceutical Description and Business Overview Table 135. Jiangsu Enhua Pharmaceutical Ropivacaine Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2016-2021) Table 136. Jiangsu Enhua Pharmaceutical Ropivacaine Product Table 137. Jiangsu Enhua Pharmaceutical Recent Developments/Updates Table 138. Hebei Yipin Pharmaceutical Corporation Information Table 139. Hebei Yipin Pharmaceutical Description and Business Overview Table 140. Hebei Yipin Pharmaceutical Ropivacaine Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2016-2021) Table 141. Hebei Yipin Pharmaceutical Ropivacaine Product Table 142. Hebei Yipin Pharmaceutical Recent Developments/Updates Table 143. Zhejiang Xianju Pharmaceutical Corporation Information Table 144. Zhejiang Xianju Pharmaceutical Description and Business Overview Table 145. Zhejiang Xianju Pharmaceutical Ropivacaine Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2016-2021) Table 146. Zhejiang Xianju Pharmaceutical Ropivacaine Product Table 147. Zhejiang Xianju Pharmaceutical Recent Developments/Updates Table 148. Hainan Sida Pharmaceutical Corporation Information Table 149. Hainan Sida Pharmaceutical Description and Business Overview Table 150. Hainan Sida Pharmaceutical Ropivacaine Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2016-2021) Table 151. Hainan Sida Pharmaceutical Ropivacaine Product Table 152. Hainan Sida Pharmaceutical Recent Developments/Updates Table 153. Xi'an Hanfeng Pharmaceutical Corporation Information Table 154. Xi'an Hanfeng Pharmaceutical Description and Business Overview Table 155. Xi'an Hanfeng Pharmaceutical Ropivacaine Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2016-2021) Table 156. Xi'an Hanfeng Pharmaceutical Ropivacaine Product Table 157. Xi'an Hanfeng Pharmaceutical Recent Developments/Updates Table 158. Chenxin Pharmaceutical Corporation Information Table 159. Chenxin Pharmaceutical Description and Business Overview Table 160. Chenxin Pharmaceutical Ropivacaine Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2016-2021) Table 161. Chenxin Pharmaceutical Ropivacaine Product Table 162. Chenxin Pharmaceutical Recent Developments/Updates Table 163. Shaanxi Bosen Biopharmaceutical Corporation Information Table 164. Shaanxi Bosen Biopharmaceutical Description and Business Overview Table 165. Shaanxi Bosen Biopharmaceutical Ropivacaine Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2016-2021) Table 166. Shaanxi Bosen Biopharmaceutical Ropivacaine Product Table 167. Shaanxi Bosen Biopharmaceutical Recent Developments/Updates Table 168. Qilu Pharmaceutical Corporation Information Table 169. Qilu Pharmaceutical Description and Business Overview Table 170. Qilu Pharmaceutical Ropivacaine Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2016-2021) Table 171. Qilu Pharmaceutical Ropivacaine Product Table 172. Qilu Pharmaceutical Recent Developments/Updates Table 173. Shenyang Sansheng Pharmaceutical Corporation Information Table 174. Shenyang Sansheng Pharmaceutical Description and Business Overview Table 175. Shenyang Sansheng Pharmaceutical Ropivacaine Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2016-2021) Table 176. Shenyang Sansheng Pharmaceutical Ropivacaine Product Table 177. Shenyang Sansheng Pharmaceutical Recent Developments/Updates Table 178. Production Base and Market Concentration Rate of Raw Material Table 179. Key Suppliers of Raw Materials Table 180. Ropivacaine Distributors List Table 181. Ropivacaine Customers List Table 182. Ropivacaine Market Trends Table 183. Ropivacaine Growth Drivers Table 184. Ropivacaine Market Restraints Table 185. Global Ropivacaine Sales Forecast by Type (2022-2027) & (K Doses) Table 186. Global Ropivacaine Sales Market Share Forecast by Type (2022-2027) Table 187. Global Ropivacaine Revenue Forecast by Type (2022-2027) & (US$ Million) Table 188. Global Ropivacaine Revenue Market Share Forecast by Type (2022-2027) Table 189. Global Ropivacaine Sales Forecast by Application (2022-2027) & (K Doses) Table 190. Global Ropivacaine Sales Market Share Forecast by Application (2022-2027) Table 191. Global Ropivacaine Revenue Forecast by Application (2022-2027) & (US$ Million) Table 192. Global Ropivacaine Revenue Market Share Forecast by Application (2022-2027) Table 193. Global Ropivacaine Sales Forecast by Region (2022-2027) & (K Doses) Table 194. Global Ropivacaine Sales Market Share Forecast by Region (2022-2027) Table 195. Global Ropivacaine Revenue Forecast by Region (2022-2027) & (US$ Million) Table 196. Global Ropivacaine Revenue Market Share Forecast by Region (2022-2027) Table 197. Research Programs/Design for This Report Table 198. Key Data Information from Secondary Sources Table 199. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Ropivacaine Figure 2. Global Ropivacaine Market Share by Type in 2020 & 2027 Figure 3. Lumbar Epidural Administration Product Picture Figure 4. Thoracic Epidural Administration Product Picture Figure 5. Regional Block Product Picture Figure 6. Global Ropivacaine Market Share by Application in 2020 & 2027 Figure 7. Anesthesia Figure 8. Systemic Neuropathic Pain Figure 9. Postherpes Pain Figure 10. Post-Operative Pain Figure 11. Surgical Analgesia Figure 12. Labor Analgesia Figure 13. Other Figure 14. Global Ropivacaine Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 15. Global Ropivacaine Market Size 2016-2027 (US$ Million) Figure 16. Global Ropivacaine Sales 2016-2027 (K Doses) Figure 17. Global Ropivacaine Market Size Market Share by Region: 2016 VS 20210 VS 2027 Figure 18. Ropivacaine Sales Share by Manufacturers in 2020 Figure 19. Global Ropivacaine Revenue Share by Manufacturers in 2020 Figure 20. The Global 5 and 10 Largest Ropivacaine Players: Market Share by Revenue in 2020 Figure 21. Ropivacaine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021 Figure 22. Global Ropivacaine Sales Market Share by Region (2016-2021) Figure 23. Global Ropivacaine Sales Market Share by Region in 2020 Figure 24. Global Ropivacaine Revenue Market Share by Region (2016-2021) Figure 25. Global Ropivacaine Revenue Market Share by Region in 2020 Figure 26. U.S. Ropivacaine Revenue Growth Rate (2016-2021) (US$ Million) Figure 27. Canada Ropivacaine Revenue Growth Rate (2016-2021) (US$ Million) Figure 28. Germany Ropivacaine Revenue Growth Rate (2016-2021) (US$ Million) Figure 29. France Ropivacaine Revenue Growth Rate (2016-2021) (US$ Million) Figure 30. U.K. Ropivacaine Revenue Growth Rate (2016-2021) (US$ Million) Figure 31. Italy Ropivacaine Revenue Growth Rate (2016-2021) (US$ Million) Figure 32. Russia Ropivacaine Revenue Growth Rate (2016-2021) (US$ Million) Figure 33. China Ropivacaine Revenue Growth Rate (2016-2021) (US$ Million) Figure 34. Japan Ropivacaine Revenue Growth Rate (2016-2021) (US$ Million) Figure 35. South Korea Ropivacaine Revenue Growth Rate (2016-2021) (US$ Million) Figure 36. India Ropivacaine Revenue Growth Rate (2016-2021) (US$ Million) Figure 37. Australia Ropivacaine Revenue Growth Rate (2016-2021) (US$ Million) Figure 38. Taiwan Ropivacaine Revenue Growth Rate (2016-2021) (US$ Million) Figure 39. Indonesia Ropivacaine Revenue Growth Rate (2016-2021) (US$ Million) Figure 40. Thailand Ropivacaine Revenue Growth Rate (2016-2021) (US$ Million) Figure 41. Malaysia Ropivacaine Revenue Growth Rate (2016-2021) (US$ Million) Figure 42. Philippines Ropivacaine Revenue Growth Rate (2016-2021) (US$ Million) Figure 43. Vietnam Ropivacaine Revenue Growth Rate (2016-2021) (US$ Million) Figure 44. Mexico Ropivacaine Revenue Growth Rate (2016-2021) (US$ Million) Figure 45. Brazil Ropivacaine Revenue Growth Rate (2016-2021) (US$ Million) Figure 46. Argentina Ropivacaine Revenue Growth Rate (2016-2021) (US$ Million) Figure 47. Turkey Ropivacaine Revenue Growth Rate (2016-2021) (US$ Million) Figure 48. Saudi Arabia Ropivacaine Revenue Growth Rate (2016-2021) (US$ Million) Figure 49. UAE Ropivacaine Revenue Growth Rate (2016-2021) (US$ Million) Figure 50. Sales Market Share of Ropivacaine by Type (2016-2021) Figure 51. Sales Market Share of Ropivacaine by Application (2016-2021) Figure 52. Sales Market Share of Ropivacaine by Application in 2020 Figure 53. Revenue Share of Ropivacaine by Application (2016-2021) Figure 54. Revenue Share of Ropivacaine by Application in 2020 Figure 55. Manufacturing Cost Structure of Ropivacaine Figure 56. Manufacturing Process Analysis of Ropivacaine Figure 57. Ropivacaine Industrial Chain Analysis Figure 58. Channels of Distribution Figure 59. Distributors Profiles Figure 60. Bottom-up and Top-down Approaches for This Report Figure 61. Data Triangulation Figure 62. Key Executives Interviewed

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

Publisher: QY Research
Chat with us